Walter V. Klemp - Nov 16, 2022 Form 4 Insider Report for Moleculin Biotech, Inc. (MBRX)

Role
CEO and President, Director
Signature
/s/ Jonathan P. Foster by Power of Attorney
Stock symbol
MBRX
Transactions as of
Nov 16, 2022
Transactions value $
$107,871
Form type
4
Date filed
11/18/2022, 07:34 PM
Previous filing
Jul 15, 2022
Next filing
Nov 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MBRX Common Stock Purchase $82.6K +85.2K +36.66% $0.97 318K Nov 16, 2022 Direct F1
transaction MBRX Common Stock Purchase $25.3K +24.7K +7.79% $1.02 342K Nov 17, 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $0.935 to $1.02. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 This transaction was executed in multiple trades at prices ranging from $0.995 to $1.04. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.